Clinical Trials on Ejaculation Delayed

Total 50633 results

University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase XI - 16

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 4 - 4

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dose Alteration Study - 1

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase IX - 14

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2

Opioid-Related Disorders

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Long-term Behavior Change - 1

Amphetamine-related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 1 - 1

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1

Opioid-Related Disorders

United States
Indivior Inc.

Completed

Safety and Tolerability of Buprenorphine/Naloxone Film Strips

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase I - 3

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine. Phase V - 6

Opioid-Related Disorders

United States
University Hospital, Montpellier

Completed

Diagnosis of Short Stature in Children : Study of a Cohort of Small-sized Consulting Patients

Short Stature | Growth Delay

France
Indiana University
National Institute on Drug Abuse (NIDA)

Recruiting

Maternal Brain Imaging in Opioid Use Disorder

Substance-Related Disorders | Pregnancy Related | Narcotic-Related Disorders | Substance Use | Opioid Use Disorder | Buprenorphine Dependence

United States
Indivior Inc.

Completed

Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) (OPUS R)

Naloxone | Drug Abuse | Opiate Dependence | Buprenorphine | Opiate-related Disorders
Indivior Inc.

Completed

Open-Label Treatment Extension Study

Opioid Use Disorder | Opioid-related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effect of Clonidine on Responses to Imagery Scripts

Cocaine Abuse | Heroin Abuse

United States
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
ER/LA Opioid REMS Program Companies (RPC)

Unknown

ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases

Drug Abuse | Opioid-related Disorders | Narcotic Abuse | Opioid Addiction
NYU Langone Health
National Institutes of Health (NIH)

Recruiting

Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder

Problems Related to Social Environment

United States
Chestnut Health Systems

Recruiting

Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: FAIR (PRE-FAIR)

Opioid-Related Disorders | Mental Health Impairment | Child Neglect | Stimulant-Related Disorder

United States
University of Utah

Completed

Perinatal Care and Medication Assisted Treatment: Carbon/Emery Counties

Pregnancy Related | Opioid-use Disorder

United States
Yih-Ing Hser
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Not yet recruiting

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) (RXR)

Substance-Related Disorders | Opioid-Related Disorders | Narcotic-Related Disorders

United States
West Virginia University
National Institute on Drug Abuse (NIDA)

Recruiting

Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder

Opioid-Related Disorders

United States
University of Pennsylvania
Yale University

Recruiting

Tau PET Imaging in Opioid Use Disorder

Opioid-Related Disorders

United States
Geisinger Clinic

Completed

Evaluation of a Medication Disposal Program in Primary Care

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 2

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 3

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Fetal Neurobehavioral Development in Methadone Maintained Pregnancies

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Feasibility Study of Take-Home LAAM Medication - 3

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Improving Learning-based Treatment of Cocaine Dependence With Medication

COCAINE-RELATED DISORDERS

United States
National Institute on Drug Abuse (NIDA)

Completed

Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9

Opioid-Related Disorders

United States
University of Pennsylvania

Completed

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

Opioid-Related Disorders

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Naltrexone-P1 A-Cocaine

Cocaine-related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Opioid Agonist and Antagonist Effects on Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Liquid vs. Tablet Buprenorphine - 6

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 3 - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Assessment of Tramadol as a Treatment for Opioid Addiction

Opioid-Related Disorders

United States
Denver Health and Hospital Authority
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing

Alcohol Related Disorders

United States, Canada
US Department of Veterans Affairs

Completed

Effect Of Case Management Following Discharge From Methadone Treatment

Opioid-Related Disorders

United States

Clinical Trials on Ejaculation Delayed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations